Watch: Covaxin meets WHO standards of protection

  • 2 years ago
The World Health Organisation (WHO) has granted emergency use authorisation to Bharat Biotech's Covaxin. This development is being welcomed by the roughly 15 crore Indians who are recipients of Covaxin, the country's first indigenous Covid-19 vaccine.

The extended delay over approvals for Covaxin left thousands of Indians, including students, working professionals and families divided. Over a million others were waiting for countries to recognize the jab.

Recommended